Webinar on public funding for nuclear innovation in Europe
On 27 October 2026, european economics hosted a webinar on public funding for nuclear innovation in Europe, bringing together a qualified audience of industry stakeholders.
Our presentation
Marc ISABELLE
🗓 IPCEI Innovative Nuclear Technologies webinar – Tuesday 27 October, 11:00
In his presentation entitled Crossing the Valley of Death with IPCEI Nuclear, our President and Founder outlined the public funding levers that can take nuclear innovation from R&D to first industrial deployment.
Why nuclear innovation needs public funding?
An innovative nuclear project requires 10 to 15 years and billions of euros of investment before its first industrial deployment, with high technological and regulatory risks. Its benefits are largely public: decarbonisation, energy security, sovereignty and jobs. Private capital alone is therefore not enough to bridge this “valley of death” between R&D and commercial roll-out.
Public money already underpins nuclear investment in Europe. The European Commission has cleared State aid for new nuclear plants in the United Kingdom (2014), Hungary (2017), the Czech Republic (2024) and Poland (2025). For Poland’s first nuclear power plant (3 x 1,250 MW, €42 billion), the support package includes State equity of around 30%, a 100% State guarantee on debt and a 40-year two-way contract for difference.
Funding instruments to combine across the project life cycle
Upstream, EU R&D programmes, such as Euratom and Horizon Europe, help seed the technology. The IPCEI, the Innovation Fund, which funds up to 60% of eligible costs, and contracts for difference then close the funding gap. The European Investment Bank and InvestEU provide long-term debt and guarantees, before private capital takes over for deployment at scale. Key message: these instruments form a single capital stack, to be coordinated from day one.
Lessons from previously approved IPCEIs
Between 2018 and 2025, 11 IPCEIs were approved in 23 Member States, with €37.6 billion of State aid. This aid has unlocked more than €60 billion of private investment.
The IPCEI funds R&D and first industrial deployment, up to TRL 8. Aid can cover up to 100% of eligible costs, and the amount is calculated on the basis of the funding gap. A clawback mechanism applies if the project proves more profitable than expected, and each IPCEI must involve companies from at least four Member States. The notification to the European Commission, required above €50 million of aid for direct participants, remains a demanding step: in the most recent IPCEIs, the failure rate at this stage reached 40%.
The IPCEI Innovative Nuclear Technologies
The IPCEI Innovative Nuclear Technologies has been endorsed by 13 Member States since April 2025, with France coordinating fission and Italy coordinating fusion. It covers three workstreams:
- reactors: SMRs and advanced reactors;
- fuels: innovative fuels, fuel cycle and waste management;
- supply chain: materials, components, manufacturing and engineering.
National calls for expression of interest are under way, including Italy’s, open until 3 December 2026. According to the indicative timeline presented, national selection would take place in January 2027, and the first grant instalment is expected in the first quarter of 2028.
At the heart of nuclear innovation funding
european economics is a consultancy specialising in public funding for strategic industrial projects in Europe. Since 2009, the firm has supported 262 major industrial projects and helped secure €46 billion in public funding, with a 100% success rate on State aid notifications to the European Commission. Since 2018, it has supported 151 projects across 14 IPCEIs in 13 Member States. In the 11 IPCEIs already approved, companies supported by european economics obtained average aid of €169 million per project, compared with €81 million for other companies.
Let’s keep the conversation going
We would like to thank all participants for attending.
Are you preparing a project for the IPCEI Innovative Nuclear Technologies or looking to assess your public funding options in Europe? Contact us to arrange a meeting!
